ACCUTANE 20 - Hutech Labs

Accutane, developed by Hoffmann-La Roche and introduced in 1982, set a new standard in acne treatment with its unique mechanism targeting severe, persistent acne. Unlike topical retinoids, Accutane (isotretinoin) operates systemically, reducing sebaceous gland function to address acne at its root. Roche held the patent in the U.S. until 2002, after which other isotretinoin brands like Claravis and Amnesteem entered the market. Despite its effectiveness, Accutane remains controversial due to its association with significant side effects, including mental health risks and teratogenicity, making strict regulation through the iPLEDGE program necessary​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about ACCUTANE 20 by Hutech Labs, consult with your doctor or healthcare professional.